reviewTop 1% cited
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
The Lancet Infectious Diseases · 2013 · Vol. 13(9) · pp. 785–796
L. Silvia Muñoz-Price✉(Jackson Memorial Hospital)Laurent Poirel(Inserm)Robert A. Bonomo(Louis Stokes Cleveland VA Medical Center)Mitchell J. Schwaber(Israel Ministry of Health)George L. Daikos(National and Kapodistrian University of Athens)Martin Cormican(Ollscoil na Gaillimhe – University of Galway)Giuseppe Cornaglia(University of Verona)Javier Garau(Universitat de Barcelona)Marek Gniadkowski(Narodowy Instytut Leków)Mary K. Hayden(Rush University Medical Center)Kanimozhi Kumarasamy(University of Madras)David M. Livermore(Public Health England)Juan José Maya(Centro Internacional de Entrenamiento e Investigaciones Medicas)Patrice Nordmann(Bicêtre Hospital)Jean B. Patel(Centers for Disease Control and Prevention)David L. Paterson(Royal Brisbane and Women's Hospital)Johann Pitout(University of Calgary)María Virginia Villegas(Centro Internacional de Entrenamiento e Investigaciones Medicas)Hui Wang(Peking University People's Hospital)Neil Woodford(Public Health England)John P. Quinn(AstraZeneca (United States))
Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyAntibiotic Use and ResistanceTigecyclineColistinKlebsiella pneumoniaeEpidemiologyImipenemAntibioticsMedicineIntensive care medicineBiologyMicrobiology
MeSH terms
TigecyclineAminoglycosidesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesColistinCommunicable Disease ControlGeographyHumansKlebsiella InfectionsKlebsiella pneumoniaeMinocyclineBacteremiaTreatment Outcome
Citations
1,629
FWCI
44.46
field-weighted impact
References
134
Percentile
100%
vs. same field & year
Citations per year
Cited by
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
The Journal of Infectious Diseases · 2017 · 1,509 citations
Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance
Antimicrobial Agents and Chemotherapy · 2015 · 820 citations
Infections caused by KPC-producing <i>Klebsiella pneumoniae</i> : differences in therapy and mortality in a multicentre study
Journal of Antimicrobial Chemotherapy · 2015 · 506 citations
Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
Antimicrobial Agents and Chemotherapy · 2014 · 602 citations
Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods
Frontiers in Microbiology · 2016 · 719 citations
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
The Lancet Infectious Diseases · 2015 · 5,271 citations
References
Novel Carbapenem-Hydrolyzing β-Lactamase, KPC-1, from a Carbapenem-Resistant Strain of<i>Klebsiella pneumoniae</i>
Antimicrobial Agents and Chemotherapy · 2001 · 1,610 citations
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
Journal of Antimicrobial Chemotherapy · 2010 · 708 citations
Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
Clinical Microbiology Reviews · 2012 · 1,184 citations
OXA-48-like carbapenemases: the phantom menace
Journal of Antimicrobial Chemotherapy · 2012 · 891 citations
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
The Lancet Infectious Diseases · 2010 · 2,895 citations
Tracking a Hospital Outbreak of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> with Whole-Genome Sequencing
Science Translational Medicine · 2012 · 873 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.